Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-04

FDA Approved: DESCOVY — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved DESCOVY (emtricitabine and tenofovir alafenamide) as the original application for treatment of HIV-1 infection in adults and certain pediatric pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Descovy (emtricitabine/tenofovir alafenamide)

Snippet

ORIG AP for DESCOVY (EMTRICITABINE AND TENOFOVIR ALAFENAMIDE)